2.4. Low Concentrations of Shikonin Have a Synergistic Effect When Combined with PI3K-Akt-mTOR Inhibitor (BEZ235) to Reduce the Survival of Chemoresistant Lung Cancer Cells. The gene discussed is MTOR; the disease is lung carcinoma.